Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 295: C1238-C1246, 2008. First published September 11, 2008; doi:10.1152/ajpcell.00349.2008
0363-6143/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/C1238    most recent
00349.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lees, S. J.
Right arrow Articles by Booth, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lees, S. J.
Right arrow Articles by Booth, F. W.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells

Simon J. Lees,1 Tom E. Childs,1 and Frank W. Booth1,2,3

Departments of 1Biomedical Sciences and 2Medical Pharmacology and Physiology and 3Dalton Cardiovascular Institute, University of Missouri, Columbia, Missouri

Submitted 3 July 2008 ; accepted in final form 2 September 2008


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Previously, we have demonstrated that forkhead box O3a (FOXO3a) overexpression increased p27Kip1 promoter activity and protein expression, whereas it decreased proliferation in muscle precursor cells (MPCs). The objectives of the present study were to 1) locate and identify FOXO regulatory elements in the rat p27Kip1 promoter using deletion analysis of a promoter/reporter construct and 2) determine if age-related differences exist in FOXO-induced p27Kip1 expression. The full-length (–4.0/+0.4 kb) rat p27Kip1 promoter construct revealed that both FOXO1 and FOXO3a induced an increase in transcriptional activity. Interestingly, MPCs isolated from old animals exhibited an increased FOXO3a-induced p27Kip1 promoter activity compared with MPCs isolated from young animals. Deletion of a 253-bp portion of the 5'-untranslated region (UTR) resulted in a significant decrease in FOXO-induced p27Kip1 promoter expression. Site-specific mutation of a daf-16 family protein-binding element (DBE) within this 253-bp portion of the 5'-UTR also demonstrated a decrease in FOXO-induced p27Kip1 promoter expression. These data suggest that a putative FOXO regulatory element located in the 5'-UTR of the rat p27Kip1 gene plays a role in the age-dependent differences in FOXO3a-dependent p27Kip1 promoter expression. These findings have implications for developing treatment strategies aimed at increasing the proliferation of MPCs and regenerative capacity of aged skeletal muscle.

satellite cell; skeletal muscle; proliferation; 5'-untranslated region; daf-16 family protein-binding element; forkhead box O

EMERGING EVIDENCE suggests that forkhead box O (FOXO) transcription factors are at the nexus of aging, metabolism, and cell fate/function (9). The primary regulation of FOXO family proteins is downstream of insulin and IGF signaling. Akt-mediated phosphorylation of FOXO results in nuclear exclusion and inhibition of transcriptional activity (7, 8, 23, 30, 33). However, despite extensive study into the multitude of functional roles, the details of the regulatory regions for targets of FOXO are still mostly elusive.

FOXO proteins play a key role in multiple conditions of skeletal muscle wasting. Several models of skeletal muscle atrophy cause upregulation of the transcripts of the muscle-specific ubiquitin ligases muscle ring finger-1 (MuRF-1) and muscle atrophy F-box (MAFbx/atrogin-1) (5). Followup experiments revealed that overexpression of MAFbx induced myotube atrophy in culture, whereas mice lacking either the MuRF-1 or MAFbx genes were resistant to denervation-induced muscle atrophy (5). A mutant FOXO that was constitutively active induced MAFbx expression and caused atrophy in myotubes in culture (34). Moreover, RNA inhibitor knock down of FOXO3a in vivo decreased MAFbx expression (34). Interestingly, recent findings have revealed increased FOXO3a mRNA (32) in sarcopenia, which is defined as an age-associated loss of skeletal muscle mass and strength.

Muscle precursor cells (MPCs) are required for normal regenerative (35) and hypertrophic responses in skeletal muscle (1). However, sarcopenia has been linked to impaired skeletal muscle regeneration (6) and hypertrophy (3) as well as impaired MPC function (4, 12, 27). Previous work from our laboratory has demonstrated elevated nuclear FOXO1 and p27Kip1 protein levels in MPCs isolated from sarcopenic animals (27). p27Kip1 is a key cell cycle inhibitor that has been shown to be regulated by FOXO (14, 29, 31). Furthermore, we have demonstrated that adenovirus-mediated FOXO3a overexpression increased p27Kip1 promoter activity and protein expression in MPCs (31). This FOXO3a-mediated increase in p27Kip expression was associated with a decrease in 5-bromo-2'-deoxyuridine incorporation and cell number (31).

The purpose of the present study was twofold: 1) to locate and identify FOXO regulatory elements on the p27Kip1 promoter using deletion analysis of a promoter/reporter construct and 2) to determine if age-related differences exist in FOXO-induced p27Kip1 expression at the identified regulatory element.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Missouri (Columbia, MO). Fischer-344 x Brown Norway F1 hybrid male rats (3 and 32 mo old) were obtained from the National Institute on Aging. Animals were housed at 21°C on a 12:12-h light-dark cycle and allowed free access to food and water. At the time of death, animals were given an intraperitoneal injection of ketamine (80 mg/kg), xylazine (10 mg/kg), and acepromazine (4 mg/kg), and muscles were then excised.

MPC isolation and culture. MPC isolation was modified from Allen et al. (2) as previously described (24, 25). Briefly, cells isolated from the gastrocnemius and plantaris muscles by pronase digestion were preplated for 24 h on tissue culture-treated 150-mm plates. After the 24-h preplate, cells were seeded onto Matrigel (BD Biosciences, San Jose, CA)-coated 150-mm plates (0.1 mg/ml Matrigel for 60 min at 37°C) and cultured for 3 days in growth media (GM; 20% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 40 µg/ml gentamicin in Ham's F-10) in a humidified incubator with 5% O2-5% CO2-90% N2 at 37°C (HERAcell, Thermo Scientific). After 3 days, cells reached ~80% confluence. Cells were then passaged one time and seeded onto appropriate Matrigel tissue culture plates. Greater than 95% desmin- and MyoD-positive cells are obtained using this isolation protocol (data not shown). As media depth is an important concern for 5% O2 culture conditions (36), 1.5 ml of GM were used for experiments carried out in six-well culture plates (25,000 cells/well). For experiments where MPC differentiation was induced, cells were washed once with PBS, and the media were replaced with differentiation media (DM), which consisted of 2% horse serum in DMEM.

DNA constructs, transfection, and promoter activity. The rat muscle creatine kinase (CK-M) promoter construct (–1500/+24 bp) was cloned from genomic DNA isolated from Fischer-344 x Brown Norway F1 hybrid skeletal muscle by PCR using the following primers: forward 5'-CGACGCGTCGTGGGCAGAGTGGAGTGAAGCCATGC-3' and reverse 5'-TCCCCCGGGGGAGTCTTTGCTGTGGAGGTGGTGGTGAC-3'. The cloned promoter was then ligated into the pGL3-Basic firefly luciferase reporter vector (Promega, Madison, WI). The cloned CK-M promoter sequence was verified by DNA sequencing using an Applied Biosystems 3730 DNA Analyzer and Applied Biosystems Prism BigDye Terminator cycle sequencing chemistry (Applied Biosystems, Foster City, CA). Expression plasmids for FOXO1 and its triple mutant, in which the inhibitory Akt threonine and serine phosphoresidues were mutated by substitution with alanine residues (FOXO1 A3), were a kind gift from Dr. Terry Unterman (in pALTER-MAX, Promega). Expression plasmids for FOXO3a and its triple mutant, in which the inhibitory Akt threonine and serine phosphoresidues were mutated by substitution with alanine residues (FOXO3a A3), were a kind gift from Dr. Paul Coffer (in pECE). The full-length rat p27Kip1 promoter (–4362/+0.421 kb) was cloned using the primers previously described (24). The full-length sequence is shown in supplemental Fig. 1S along with the human sequence.1 Deletion constructs for the p27Kip1 promoter construct were created from the full-length (–4362/+0.421 kb) p27Kip1 construct using the primers shown in Table 1. The deletion of ~253 bp from the 5'-untranslated region (UTR) was achieved by restriction endonuclease digestion with HindIII (Table 1). The NF-{kappa}B cis-reporter construct contains five repeats of the transcription recognition sequence (5'-TGGGGACTTTCCGC-3') linked to a basic promoter element (TATA box) and the firefly luciferase gene (Stratagene, La Jolla, CA).


View this table:
[in this window]
[in a new window]

  		Table 1. Primers used to clone the full-length p27Kip1 promoter and deletion constructs

 
The QuikChange Lightning Site-Directed Mutagenesis kit (Stratgene) was used for site-directed mutageneis of the daf-16 family protein-binding element (DBE) site in the 5'-UTR (+348 to +355 bp) of the p27Kip1 gene from 5'-TTGTTTAT-3' to 5'-TCCCCTAT-3' using the following primers: forward 5'-CAGGGGCGTTTCGCTTTTGTTTGGTTTTGTCCCCTATTTCATTTCATTTTTTTTTTTTTCGGAGA-3' and reverse 5'-TCTCCGAAAAAAAAAAAAATGAAATGAAATAGGGGACAAAACCAAACAAAAGCGAAACGCCCCTG-3'. Successful mutation of the DBE was verified by DNA sequencing using an Applied Biosystems 3730 DNA Analyzer and Applied Biosystems Prism BigDye Terminator cycle sequencing chemistry (Applied Biosystems).

Transient transfections were carried out immediately after the cells had been seeded in antibiotic-free GM using Fugene 6 (Roche Applied Science, Indianapolis, IN) following the manufacturer's instructions. The phRL-null Renilla luciferase reporter vector (Promega) was cotransfected in each experiment and used as an internal control promoter to normalize for transfection efficiency. For FOXO overexpression experiments, 0.1 µg/well of expression vector containing either FOXO1 or FOXO1A3 in pALTER-MAX or FOXO3a or FOXO3a A3 in pECE were used. A total of 0.7 µg of DNA were used for both firefly and Renilla luciferase reporter constructs at a firefly-to-Renilla ratio of 20:1. Cells were lysed using passive lysis buffer (Promega) and stored at –80°C. Firefly and Renilla luminescence were measured using the Dual-Luciferase Reporter Assay System (Promega) on a Veritas microplate luminometer (Turner BioSystems, Sunnyvale, CA).

Western blot analysis. After 2 days in GM, cells were lysed with RIPA buffer containing 1.04 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 800 nM aprotinin, 20 µM leupeptin, 40 µM bestatin, 15 µM pepstatin A, 14 µM E-64, and phosphatase inhibitor cocktail 1 (P2850, Sigma-Aldrich, St. Louis, MO; a proprietary mix of cantharidin, bromotetramisole, and microcystin LR used at 1:100 dilution). Cell lysates were then frozen and stored at –80°C. Samples were thawed and then centrifuged at 12,000 g (4°C) for 15 min, the supernatant was collected, the protein concentration was determined using the DC protein assay, and samples were diluted to equal concentrations (0.4 mg/ml) in SDS reducing buffer. Equal amounts of protein were loaded and separated by SDS-PAGE and transferred to nitrocellulose membranes (Osmonics). To ensure equal loading, nitrocellulose membranes were stained with Ponceau S (Sigma-Aldrich), which allows for both the qualitative visualization and quantitation of the amount or protein in a given lane (22). Phospho-AktSerine473 antibody was purchased from Cell Signaling Technology (Beverly, MA). Horseradish peroxidase-conjugated secondary IgG antibody was purchased from Pierce Biotechnology (Rockford, IL). Immunocomplexes were visualized using Supersignal West Dura Extended Duration Substrate (Pierce Biotechnology). Signal bands were scanned using a Kodak Image Station 4000R Digital Imaging System (Eastman Kodak, Rochester, NY) and quantified using Kodak molecular imaging software (version 4.0).

Statistics. Data are presented as means ± SE. Sample sizes are indicated for each measurement in the figures, where n represents independent isolations from separate animals. Comparisons between groups were done using ANOVA (SigmaStat, version 3.1). Significance was accepted at P ≤ 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Previously published work from our laboratory has demonstrated that adenoviral FOXO3a overexpression in MPCs caused an increase in p27Kip1 protein and a decrease in proliferation, as measured by 5-bromo-2'-deoxyuridine incorporation and cell number (31). Moreover, overexpression of both FOXO3a and FOXO3a A3 caused an increase in promoter activity of the human p27Kip1 promoter construct. Therefore, to extend these findings, we cloned the rat –4.0/+0.4 p27Kip1 promoter construct and determined the effects of both FOXO1 and FOXO3a and their triple mutant counterparts (FOXO1 A3 and FOXO3a A3), which are not responsive to Akt-induced nuclear export/inhibition. Overexpression of FOXO1 and FOXO3a in rat MPCs resulted in ~1.5- and ~6-fold increases, respectively, in rat –4.0/+0.4 p27Kip1 promoter activity (Fig. 1). Moreover, the FOXO-induced p27Kip1 response was further increased for both FOXO1 A3 and FOXO3a A3, resulting in ~2- and 14-fold increases in rat –4.0/+0.4 p27Kip1 promoter activity, respectively, compared with the empty vector. These data establish that 1) our –4.0/+0.4 rat p27Kip1 promoter construct is expressed in proliferating rat MPCs and is responsive to both FOXO1 and FOXO3a and 2) the triple mutants FOXO1 A3 and FOXO3a A3 enhance this response compared with the wild type.


Figure 1
View larger version (9K):
[in this window]
[in a new window]

  		Fig. 1. Forkhead box O (FOXO)-mediated p27Kip1 promoter activity in growth media. A: muscle precursor cells (MPCs) were transiently transfected with the full-length rat –4.0/+0.4 p27Kip1 promoter/reporter construct and cotransfected with either wild-type FOXO1, mutant FOXO1 lacking the three Akt inhibitory phosphorylation sites (A3), or the corresponding empty vector (EV). B: MPCs were cotransfected with either wild-type FOXO3a, FOXO3a A3, or the corresponding EV. Data are presented as group means ± SE; n = 4 for FOXO1 and 6 for FOXO3a. *Significantly different from EV; #significantly different from FOXO1 or FOXO3a.

 
p27Kip1 is a key cell cycle regulator that induces cell cycle arrest. The temporal regulation of p27Kip1 expression can dramatically affect the function of MPCs in skeletal muscle repair/regeneration. For example, during regeneration, MPCs must first proliferate and then differentiate. In the proliferation stage, increased p27Kip1 expression would impair MPC proliferation and subsequent repair/regeneration. However, for MPCs to effectively become new myonuclei, cell cycle arrest must occur to allow for terminal differentiation. Therefore, upregulation of p27Kip1 at the differentiation stage would induce cell cycle arrest, which might help MPCs differentiate. By changing MPCs to low-serum media conditions (DM), MPCs upregulate p27Kip1 expression, induce cell cycle arrest, and subsequently differentiate into myotubes. These data provide further proof that the rat p27Kip1 promoter is expressed in rat MPCs as demonstrated by ~3 and ~10-fold increases after exposure to DM for 24 and 48 h, respectively (Fig. 2A). As an indicator of MPC differentiation, CK-M promoter activity was measured and increased ~4.5-fold between 24 and 48 h in DM (Fig. 2B). Since ectopic expression of p27Kip1 has been demonstrated to promote myoblast differentiation (40), the effect of FOXO3a overexpression during MPC differentiation was determined. As previously found (Fig. 1), FOXO3a increased p27Kip1 promoter activity in GM (0 h). After 24 h of exposure to DM, p27Kip1 expression increased in MPCs, and this effect was further increased when FOXO3a was overexpressed (Fig. 3A). CK-M promoter activity was not different between FOXO3a and the empty vector after 24 h of exposure to DM; however, there was a modest FOXO3a-induced increase in CK-M after 48 h of exposure to DM (Fig. 3B). Taken together, FOXO3a caused similar fold inductions in the –4.0/+0.4 p27Kip1 promoter construct in both GM and DM; therefore, we chose to focus experiments on the ability of FOXO3a-induced p27Kip1 expression in proliferating MPCs.


Figure 2
View larger version (8K):
[in this window]
[in a new window]

  		Fig. 2. MPC differentiation causes increased p27Kip1 and muscle creatine kinase (CK-M) promoter activity. A: MPCs were transiently transfected with the full-length rat p27Kip1 promoter/reporter construct and induced to differentiate by changing cell culture media conditions. MPCs were lysed either immediately before (0 h) or after 24 or 48 h of exposure to differentiation media (DM). B: MPCs were transiently transfected with the rat CK-M promoter/reporter construct and induced to differentiate by changing cell culture media conditions. MPCs were allowed to differentiate for either 24 or 48 h before they were lysed. Proliferating MPCs had undetectable CK-M promoter activities. Data are presented as group means ± SE; n = 4. *Significantly different from 24 h; #significantly different from 0 h.

 

Figure 3
View larger version (9K):
[in this window]
[in a new window]

  		Fig. 3. FOXO3a potentiates p27Kip1 and CK-M promoter activity during MPC differentiation. MPCs were transiently transfected with either wild-type FOXO3a or EV and cotransfected with the rat full-length p27Kip1 promoter/reporter construct (A) or the rat CK-M promoter/reporter construct (B). MPCs were induced to differentiate by changing cell culture media conditions and lysed at 0 h (the time when the media were changed to DM) and 24 h in A or at 24 and 48 h in B. Data are presented as group means ± SE; n = 4. *Significantly different from 0 h [p27Kip1 promoter (A)] or 24 h [CK-M promoter (B)]; #significantly different from EV.

 
To identify potential FOXO regulatory elements in the rat –4.0/–0.4 p27Kip1 promoter, we carried out a deletion analysis by sequentially removing ~500 bp from the 5'-end of the promoter (Fig. 4A). There was a modest decrease in FOXO3a-induced p27Kip1 promoter activity after the deletion of the 500 bp between –3.5 and –3.0 kb. Nonetheless, the approximately sixfold FOXO3a-induced increase in the p27Kip1 promoter was maintained even after the promoter was shortened to –0.5/+0.4 kb. Since the smallest promoter fragment from this deletion analysis retained the majority of the FOXO3a-induced p27Kip1 response, we then created 100-bp deletions from its 5'-end beginning at –0.5 kb. As a result of these deletions, there was no decrease in FOXO3a-induced p27Kip1 promoter activity to –0.2 kb (Fig. 4B). Deletion of the 100 bp between –0.2 and –0.1 kb resulted in a drop in the luciferase signal, likely due to the fact that this portion of the promoter contained the TATA box (data not shown). Since the –0.5/+0.4 p27Kip1 promoter construct retained the vast majority of the FOXO3a-induced response observed in the full-length –4.0/+0.4 construct (>5-fold increase over the empty vector), the sequence of the –0.5/+0.4 construct was analyzed. Three interesting putative regulatory elements were identified in the 5'-UTR. We next pursued the putative regulatory elements identified in the 253 bp of the 5'-UTR of the p27Kip1 gene.


Figure 4
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 4. A and B: sequential 500-bp deletions from the 5'-end of the full-length p27Kip1 promoter (A) and 100-bp deletions from the 5'-end of the –0.5/+0.4-kb p27Kip1 promoter construct (B). MPCs were transiently cotransfected with either the full-length rat p27Kip1 promoter/reporter construct (–4.0/+0.4 kb) or one of the deletion constructs shown in the schematic representation and either wild-type FOXO3a or the corresponding EV. Data are represented as the fold increase in reporter activity induced by FOXO3a compared with EV. Data are presented as group means ± SE; n = 4. *Significantly different from the –4.0/+0.4-kb promoter (in A) or –0.5/+0.4-kb promoter (in B).

 
Two of the putative regulatory elements in the 5'-UTR of the p27Kip1 promoter demonstrated homology to a conserved NF-{kappa}B binding motif (Table 2). Although the existence of regulatory elements in the 5'-UTR is less common than upstream of the transcription start site, NF-{kappa}B has previously been identified to regulate gene transcription in the 5'-UTR region of Bcl10 (38). Four of the ten nucleotides (1, 2, 3, 4, and 10) in the NF-{kappa}B binding motif are highly conserved, with the most frequent sequence being 5'-GGGACTTTCC-3' (39). The first putative NF-{kappa}B regulatory element in the rat p27Kip1 promoter (p27Kip1-1, +188/+197 bp) is 5'-GGGACGTCCC-3' and the second (p27Kip1-2, +321/+330 bp) is 5'-GGGGCGTTTC-3' (Table 2). In a pilot study to determine whether to pursue the mutation of the two putative NF-{kappa}B sites, we used a NF-{kappa}B cis-reporter construct. As expected, cells treated with TNF-{alpha} caused an increase in NF-{kappa}B cis-reporter activity (Fig. 5). However, surprisingly, TNF-{alpha} did not increase –0.5/+0.4 p27Kip1 promoter activity that contained the aforementioned two NF-{kappa}B sequences. FOXO3a, without TNF-{alpha}, increased NF-{kappa}B cis-reporter activity. Interestingly, an additive effect of FOXO3a overexpression and TNF-{alpha} treatment on NF-{kappa}B cis-reporter activity was evident, indicating that FOXO3a-induced NF-{kappa}B activation may act in a parallel pathway to TNF-{alpha}. Even though FOXO3a did increase NF-{kappa}B cis-reporter activity, TNF-{alpha}, which induced NF-{kappa}B cis-reporter activity, did not enhance –0.5/+0.4 p27Kip1 promoter activity. Therefore, we concluded that FOXO3a does not act via NF-{kappa}B signaling to increase p27Kip1 expression, and we then selected the third regulatory region for a mutational experiment.


View this table:
[in this window]
[in a new window]

  		Table 2. NF-{kappa}B binding motifs

 

Figure 5
View larger version (14K):
[in this window]
[in a new window]

  		Fig. 5. FOXO3a overexpression increases the activity of the NF-{kappa}B cis reporter construct (NF-{kappa}B cis). MPCs were transiently transfected with either the NF-{kappa}B cis reporter construct or the –0.5/+0.4-kb rat p27Kip1 promoter/reporter construct and either treated with TNF-{alpha} (20 ng/ml) or cotransfected with one of two plasmids, either FOXO3a or EV. Data are presented as group means ± SE; n = 4. *Significantly different from EV; {dagger}significantly different from FOXO3a + TNF-{alpha}.

 
The third putative regulatory element in the 5'-UTR of the p27Kip1 gene is a DBE (DBE: +348/+355 bp, 5'-TTGTTTAT-3'). Similar to NF-{kappa}B regulation in the 5'-UTR of Bcl10, a DBE has been previously reported in the 5'-UTR of the mouse atrogin-1 gene (34). The DBE sequence has been shown to bind four members of the FOXO protein family, including FOXO1 and FOXO3a (17). To test whether potential regulatory sites within the 5'-UTR are responsive to FOXO3a, a 253-bp region of the 5'-UTR (that contained putative NF-{kappa}B sites and the DBE site) was deleted from the –0.5/+0.4-kb construct, resulting in a construct we designated as –0.5/+0.2. Since the second purpose of our study was to determine if age-related differences exist in FOXO-induced p27Kip1, MPCs isolated from old rats were also tested. Interestingly, MPCs isolated from old animals demonstrated a greater upregulation of p27Kip1 compared with MPCs isolated from young animals (Fig. 6). Moreover, the 5'-UTR 253-bp deletion resulted in ~25% and ~34% decreases in the FOXO3a-induced p27Kip1 response in MPCs isolated from young and old rats, respectively (Fig. 6).


Figure 6
View larger version (9K):
[in this window]
[in a new window]

  		Fig. 6. Site-directed mutagenesis of the daf-16 family protein-binding element (DBE) within the 5'-untranslated region (UTR) decreased FOXO3a-induced p27Kip1 promoter activity. MPCs were transiently cotransfected with either the wild-type –0.5/+0.4-kb rat p27Kip1 promoter/reporter construct (DBE-wt), a promoter construct with a 253-bp deletion from the 5'-UTR (–0.5/+0.2), or a –0.5/+0.4-kb construct with site-specific mutations in the core of the DBE (DBE-mut) shown in the schematic representation and one of two plasmids containing either wild-type FOXO3a or the corresponding EV. Data are presented as fold increases in reporter activity induced by FOXO3a compared with EV. Data are presented as group means ± SE; n = 4. *Significantly different from the DBE-wt promoter; #significantly different from the –0.5/+0.2 construct within age; {dagger}significantly different from 3-mo-old animals within the construct.

 
Previous reports have demonstrated that site-directed mutagensis of four nucleotides within the DBE core sequence prevented FOXO1 A3 binding (16). Therefore, we mutated the DBE in the –0.5/+0.4 rat p27Kip1 promoter construct (DBE-mut: +348/+355 bp, 5'-TCCCCTAT-3'), as with the sites previously mutated for pyruvate dehydrogenase kinase 4 (PDK 4) (16). Mutation of the DBE caused a decrease in the FOXO3a-induced p27Kip1 promoter activity (Fig. 6); importantly, the age differential was removed by the greater reduction in the MPCs isolated from 32-mo-old animals. It is important to note that DBE-mut resulted in a ~50% decrease in p27Kip1 promoter activity in MPCs isolated from old animals, which reduced promoter activity to the same level observed for DBE-mut in MPCs isolated from young animals (Fig. 6). These findings imply that FOXO3a caused an increased response in MPCs isolated from old animals compared with young animals, and most of the FOXO3a signaling in the 253-bp region deleted from the 5'-UTR in the –0.5/+0.2 rat p27Kip1 promoter construct acts via the DBE.

Since FOXO proteins have been demonstrated to be central to the biology of aging, metabolism, and cell fate (9), we next tested the separate effects of overexpression of FOXO1 and FOXO3a and their triple mutants in MPCs isolated from aged animals (32 mo old). We first examined FOXO1 (Fig. 7A). As demonstrated previously for the –4.0/+0.4 p27Kip1 construct, wild-type FOXO1 and mutant FOXO1 A3 overexpression in MPCs isolated from 3-mo-old animals resulted in ~1.5- and 2.5-fold increases, respectively, in –0.5/+0.4 p27Kip1 promoter activity (Fig. 7A). MPCs isolated from 32-mo-old animals exhibited similar ~1.5- and 2.5-fold increases in FOXO1 and FOXO1 A3-induced –0.5/+0.4 p27Kip1 promoter activity, respectively, as 3-mo-old animals. DBE-mut did not decrease the FOXO1-induced effect for MPCs isolated from either 3- or 32-mo-old animals. However, DBE-mut did cause a decrease in the FOXO1 A3-induced response in MPCs isolated from both 3- and 32-mo-old animals. Next, FOXO3a was tested (Fig. 7B). When wild-type FOXO3a was examined, an aging effect was observed. FOXO3a caused ~50% greater p27Kip1 promoter activity in 32-mo-old MPCs compared with 3-mo-old MPCs (Fig. 7B). Interestingly, as mentioned above, DBE-mut abolished the age difference caused by FOXO3a. Furthermore, mutant FOXO3a A3 resulted in an ~21-fold increase in p27Kip1 promoter activity in MPCs isolated from 32-mo-old animals compared with the ~10-fold increase in 3-mo-old MPCs. Importantly, in MPCs isolated from 32-mo-old animals, DBE-mut reduced the FOXO3a-induced response by >50%, which remained slightly greater than DBE-mut in MPCs isolated from 3-mo-old animals.


Figure 7
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 7. A: site-directed mutagenesis of the DBE within the 5'-UTR decreased FOXO1 A3-induced p27Kip1 promoter activity in MPCs isolated from both 3- and 32-mo-old rats. MPCs from 3- and 32-mo-old rats were transiently cotransfected with either DBE-wt or DBE-mut and with one of three plasmids containing either wild-type FOXO1, FOXO1 A3, or the corresponding EV. B: site-directed mutagenesis of the DBE within the 5'-UTR decreased FOXO3a-induced p27Kip1 promoter activity in MPCs isolated from both 3- and 32-mo-old rats. MPCs from 3- and 32-mo-old rats were transiently cotransfected with either DBE-wt or DBE-mut and with one of three plasmids containing either wild-type FOXO3a, FOXO3a A3, or the corresponding EV. Data are represented as fold increases in reporter activity induced by either FOXO1, FOXO1 A3, FOXO3a, or FOXO3a A3 compared with EV. Data are presented as group means ± SE; n = 4. *Significantly different from DBE-wt; {dagger}significantly different from 3-mo-old DBE-wt within either FoxO3a or FoxO3a A3; #significantly different from 3-mo-old DBE-mut within either FOXO1 A3 (in A) or FoxO3a A3 (in B).

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Previous reports have demonstrated that FOXO proteins induce p27Kip1 expression (31); however, the mechanism of this induction was unknown. To our knowledge, the present study is the first to identify a conserved DBE FOXO binding motif in the 5'-UTR of the rat p27Kip1 gene. Moreover, we demonstrated that site-directed mutagenesis of the 5'-UTR DBE regulatory element reduced FOXO-induced p27Kip1 expression. As FOXO proteins are implicated to be at the nexus of aging and cell fate and function (9), another key finding of the present study is that MPCs isolated from aged animals exhibit a greater upregulation of p27Kip1 promoter activity in response to FOXO3a. Interestingly, mutation of the DBE site in the –0.5 to +0.4 p27kip1 promoter eliminated the age differential observed in MPCs isolated from young and old rats in FOXO3a-induced p27Kip1 expression.

The DBE was first identified to have high-affinity binding to FOXO1, FOXO3a, and FOXO4 (17). One copy of the DBE binding sequence has been identified upstream of the Sod-3 gene (17). MnSOD is the product of Sod-3 and has been shown to be responsive to FOXO (19). Later, PDK4 gene expression has been demonstrated to be regulated by direct binding of FOXO1 to a DBE in the PDK4 promoter (16). Mutation of the DBE from 5'-TTGTTTAC-3' to 5'-TCCCCTAC-3' (DBE-mut) caused an elimination of FOXO1-induced luciferase activity and binding of FOXO1 to DBE-mut oligonucleotides using gel mobility shift assay (EMSA) (16). Although transcription factor binding sites are not as common in the 5'-UTR as upstream of the transcription start site, a DBE site has been previously identified in the atrogin-1 5'-UTR (34). Constitutively active FOXO3a has been previously shown to act on the atrogin-1 promoter and cause atrophy in muscle fibers. Sandri et al. (34) reported two DBE sites in their atrogin-1 promoter construct. One partially overlapped with the TATA box (–94), and the other was just past the transcription start site in the 5'-UTR (+2). Mutation of these sites decreased FOXO3a-induced atrogin-1 promoter activity and FOXO binding using EMSA (34).

In the present study, we identified a DBE in the 5'-UTR of the p27Kip1 gene and demonstrated that site-directed mutagenesis of this DBE resulted in significant decreases in FOXO-dependent p27Kip1 transcriptional activity. Although the DBE-mut construct still retained ~1.5- and ~3-fold increases in p27Kip1 promoter activity for FOXO1 and FOXO3a, respectively, this is likely due to that fact that p27Kip1 is a key cell cycle regulator, and there are likely many other coregulators that are involved in the upregulation of p27Kip1. Although we did not perform EMSA to measure FOXO/DNA binding in our p27Kip1 construct, we used a previously described mutation of the core sequence of the DBE that has been verified using EMSA to dramatically reduce FOXO binding (16). Interestingly, upon inspection of the upstream region of the human p27Kip1 gene, a putative DBE was observed (supplemental Fig. 1S). Although it does not align in the same region as the DBE in the rat, this may give some insight into the conservation across species. Collectively, it seems that the FOXO-induced regulation of gene expression via the DBE suggests a conserved regulatory mechanism in a group of target genes. To our knowledge, we are the first to identify this relationship for FOXO and p27Kip1.

We investigated the possibility that FOXO can act via NF-{kappa}B, as previously reported (20, 26). Although FOXO3a did cause a modest increase in the NF-{kappa}B cis-reporter construct (Fig. 5), TNF-{alpha}, a major regulator of canonical (classical) NF-{kappa}B activation, did not influence p27Kip1 transcriptional activity. Moreover, while deletion of 253 bp in the 5'-UTR that contains both putative NF-{kappa}B sites and DBE decreased FOXO3a-induced p27Kip1 promoter expression, it is important to note that the site-directed mutagenesis of the DBE in the 5'-UTR accounted for all of this response (Fig. 6). Therefore, we conclude that FOXO3a signaling in the 253-bp region deleted from the 5'-UTR in the –0.5/+0.2 rat p27Kip1 promoter construct acts via the DBE and not via NF-{kappa}B signaling.

The FOXO subfamily of proteins is a major target of Akt signaling, which transmits environmental stimuli into upregulation of target gene expression (18). Insulin and IGF-I are two growth factors that have been widely demonstrated to link Akt/FOXO signaling to increased organismal lifespan (9, 18). In terms of MPC function, previous work from our laboratory has demonstrated that IGF-I directly administered to the atrophied gastrocnemius muscle from old rats facilitated an improved regrowth of muscle mass and increased MPC proliferation following reambulation (11). We next found that IGF-I increased phosphorylation of Akt at Ser256 in MPCs, inactivating FOXO1, and thereby downregulating p27Kip1 promoter activity (28). Moreover, MPCs isolated from old rats exhibited increased cytoplasmic MnSOD and nuclear FOXO1 and p27Kip1 protein compared with MPCs isolated from young rats (27). To our knowledge, it is not currently known whether aged MPCs have elevated endogenous nuclear FOXO3a protein levels; however, MPCs isolated from regenerating aged skeletal muscle have increased p27Kip1 protein levels compared with MPCs isolated from young regenerating muscle (10). Findings from our present study revealed that FOXO3a overexpression causes a higher upregulation of p27Kip1 transcriptional activation in MPCs isolated from aged rats compared with young rats. However, when wild-type DBE and DBE-mut promoter activities were compared, without exogenous overexpression of FOXO3a, there was no effect of the mutation, and no age effect was observed (supplemental Fig. 3S). These data indicate that in cell culture GM conditions, FOXO signaling does not significantly contribute to p27Kip expression in MPCs of either age. These data contribute to our understanding of the impaired MPC activation and proliferation that occurs in aged skeletal muscle during regeneration (13).

Here, we report that overexpression of exogenous FOXO3a resulted in a 50% greater increase in p27Kip1 promoter activity in MPCs isolated from old animals compared with young animals (Fig. 7). This could be partly explained by an age-associated decrease in Akt signaling in MPCs, which is indicated by the decreased basal Akt phosphorylation in MPCs isolated from old animals compared with young animals (supplemental Fig. 2S). However, the role of Akt in aged skeletal muscle is not certain. Kimball et al. (21) found no significant change in basal Akt activity between 12 and 27 mo of age in the rat gastrocnemius muscle, whereas Edström et al. (15) observed that basal Akt phosphorylation was higher in the gastrocnemius muscle from 30-mo-old rats compared with 12-mo-old rats. To examine the effect of FOXO3a on p27Kip1 independent of Akt, we overexpressed the triple mutants FOXO1 A3 and FOXO3a A3, in which the three Akt serine phosphorylation sites have been mutated to alanines so that Akt could not phosphorylate and exclude FOXO1 and FOXO3a from the nucleus. MPCs isolated from young animals exhibited a 10-fold induction of p27Kip1 promoter activity in the presence of the triple mutant FOXO3a, whereas MPCs from old rats displayed a 21-fold induction. Since the FOXO3a A3 mutant is not responsive to the inhibitory effects of Akt signaling, an alternate signaling pathway(s) may be responsible for the age effect. For example, FOXO activities have been shown to be regulated via phosphorylation by several different kinases, acetylation, and forming interactions with coactivators (37). Therefore, it is possible that even though FOXO3a A3 would be sequestered in the nucleus in MPCs isolated from both young and old animals, other regulatory mechanisms do exist that may account for the age-associated increase in FOXO3a-induced p27Kip1 promoter activity.

In summary, we demonstrated that FOXO1- and FOXO3a-induced p27Kip1 transcriptional activity is regulated through a promoter construct that contained 400 bp of the 5'-UTR. We identified a positive DBE regulatory element in the 5'-UTR of the rat p27Kip1 gene that is responsive to both FOXO1 and FOXO3a. Moreover, MPCs isolated from aged animals exhibited a greater FOXO3a-induced p27Kip1 promoter activity compared with MPCs isolated from young animals. Interestingly, site-directed mutagenesis of the DBE site in the 5'-UTR eliminated the majority of the age-related difference in FOXO3a activation of the rat p27Kip1 gene. Together, these findings suggest that aging is associated with increased signaling through a FOXO/p27Kip1 pathway, at least in part, via a DBE found in the 5'-UTR of the p27Kip1 gene.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institute on Aging Grant RO1-AG-18780.


   ACKNOWLEDGMENTS
 
We thank Dr. Richard Tsika for critical review of the manuscript and helpful suggestions.


   FOOTNOTES
 

Address for reprint requests and other correspondence: S. J. Lees, Health and Exercise Science, Colorado State Univ., 215F Moby B complex, Fort Collins, CO 80523-1582 (e-mail: sjlees{at}cahs.colostate.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supplemental material for this article is available online at the American Journal of Physiology-Cell Physiology website. Back


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
1. Adams GR, Caiozzo VJ, Haddad F, Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 283: C1182–C1195, 2002.[Abstract/Free Full Text]

2. Allen RE, Temm-Grove CJ, Sheehan SM, Rice G. Skeletal muscle satellite cell cultures. Methods Cell Biol 52: 155–176, 1997.[Web of Science][Medline]

3. Alway SE, Degens H, Krishnamurthy G, Smith CA. Potential role for Id myogenic repressors in apoptosis and attenuation of hypertrophy in muscles of aged rats. Am J Physiol Cell Physiol 283: C66–C76, 2002.[Abstract/Free Full Text]

4. Barani AE, Durieux AC, Sabido O, Freyssenet D. Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells. J Appl Physiol 95: 2089–2098, 2003.[Abstract/Free Full Text]

5. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704–1708, 2001.[Abstract/Free Full Text]

6. Brooks SV, Faulkner JA. Contraction-induced injury: recovery of skeletal muscles in young and old mice. Am J Physiol Cell Physiol 258: C436–C442, 1990.[Abstract/Free Full Text]

7. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 21: 3534–3546, 2001.[Abstract/Free Full Text]

8. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868, 1999.[CrossRef][Web of Science][Medline]

9. Burgering BM. A brief introduction to FOXOlogy. Oncogene 27: 2258–2262, 2008.[CrossRef][Web of Science][Medline]

10. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454: 528–532, 2008.[CrossRef][Web of Science][Medline]

11. Chakravarthy MV, Davis BS, Booth FW. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89: 1365–1379, 2000.[Abstract/Free Full Text]

12. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Science 302: 1575–1577, 2003.[Abstract/Free Full Text]

13. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760–764, 2005.[CrossRef][Web of Science][Medline]

14. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 20: 9138–9148, 2000.[Abstract/Free Full Text]

15. Edstrom E, Altun M, Hagglund M, Ulfhake B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci 61: 663–674, 2006.[Abstract/Free Full Text]

16. Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375: 365–371, 2003.[CrossRef][Web of Science][Medline]

17. Furuyama T, Nakazawa T, Nakano I, Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629–634, 2000.[CrossRef][Web of Science][Medline]

18. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410–7425, 2005.[CrossRef][Web of Science][Medline]

19. Honda Y, Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J 13: 1385–1393, 1999.[Abstract/Free Full Text]

20. Kim DH, Kim JY, Yu BP, Chung HY. The activation of NF-kappaB through Akt-induced FOXO1 phosphorylation during aging and its modulation by calorie restriction. Biogerontology 9: 33–47, 2008.[CrossRef][Web of Science][Medline]

21. Kimball SR, O'Malley JP, Anthony JC, Crozier SJ, Jefferson LS. Assessment of biomarkers of protein anabolism in skeletal muscle during the life span of the rat: sarcopenia despite elevated protein synthesis. Am J Physiol Endocrinol Metab 287: E772–E780, 2004.[Abstract/Free Full Text]

22. Klein D, Kern RM, Sokol RZ. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 36: 59–66, 1995.[Web of Science][Medline]

23. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630–634, 1999.[CrossRef][Web of Science][Medline]

24. Lees SJ, Childs TE, Booth FW. p21(Cip1) expression is increased in ambient oxygen, compared to estimated physiological (5%) levels in rat muscle precursor cell culture. Cell Prolif 41: 193–207, 2008.[CrossRef][Web of Science][Medline]

25. Lees SJ, Rathbone CR, Booth FW. Age-associated decrease in muscle precursor cell differentiation. Am J Physiol Cell Physiol 290: C609–C615, 2006.[Abstract/Free Full Text]

26. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203–213, 2004.[CrossRef][Web of Science][Medline]

27. Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol 39: 1521–1525, 2004.[CrossRef][Web of Science][Medline]

28. Machida S, Spangenburg EE, Booth FW. Forkhead transcription factor FoxO1 transduces insulin-like growth factor's signal to p27Kip1 in primary skeletal muscle satellite cells. J Cell Physiol 196: 523–531, 2003.[CrossRef][Web of Science][Medline]

29. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782–787, 2000.[CrossRef][Web of Science][Medline]

30. Nakae J, Park BC, Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J Biol Chem 274: 15982–15985, 1999.[Abstract/Free Full Text]

31. Rathbone CR, Booth FW, Lees SJ. FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression. Muscle Nerve 37: 84–89, 2008.[CrossRef][Web of Science][Medline]

32. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci 62: 1407–1412, 2007.[Abstract/Free Full Text]

33. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179–17183, 1999.[Abstract/Free Full Text]

34. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399–412, 2004.[CrossRef][Web of Science][Medline]

35. Schultz E, McCormick KM. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 123: 213–257, 1994.[Web of Science][Medline]

36. Tokuda Y, Crane S, Yamaguchi Y, Zhou L, Falanga V. The levels and kinetics of oxygen tension detectable at the surface of human dermal fibroblast cultures. J Cell Physiol 182: 414–420, 2000.[CrossRef][Web of Science][Medline]

37. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297–309, 2004.[CrossRef][Web of Science][Medline]

38. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, Chang WC, Lin HI, Gao M, Cheng AL. A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem 281: 167–175, 2006.[Abstract/Free Full Text]

39. Zabel U, Schreck R, Baeuerle PA. DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J Biol Chem 266: 252–260, 1991.[Abstract/Free Full Text]

40. Zabludoff SD, Csete M, Wagner R, Yu X, Wold BJ. p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ 9: 1–11, 1998.[Abstract]




This article has been cited by other articles:


Home page
 Exp PhysiolHome page
S. S. Jump, T. E. Childs, K. A. Zwetsloot, F. W. Booth, and S. J. Lees
Fibroblast growth factor 2-stimulated proliferation is lower in muscle precursor cells from old rats
Exp Physiol, June 1, 2009; 94(6): 739 - 748.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/C1238    most recent
00349.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lees, S. J.
Right arrow Articles by Booth, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lees, S. J.
Right arrow Articles by Booth, F. W.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.